The scope of work for this grant to UM details the duties and deliverables related to the impact evaluation associated with the ProCCM CRT, and the effect of the ProCCM intervention on family planning indicators in the Yirimadio study. During the project period, Dr. Treleaven’s activities will include: Completing analysis and submitting a manuscript to a peer-review journal related to cluster-variation in under-five mortality in the Trial, as lead author; To co-lead and submit the paper related to optimal CHW ratio; Supporting additional secondary analyses and manuscript preparation, including manuscripts related to contraception, postnatal care, and malaria, as a co-author.
Funding:
Muso, Inc.
Funding Period:
01/01/2025 to 12/31/2025